Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1006 participants.
Also called NCT07938281
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 1,006 participants
- Registry
-
NCT07938281
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07938281. Randomized; double masking; primary purpose diagnostic. Start 2026-12-01 (anticipated); primary completion 2029-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial)
- Condition
- AF - Atrial Fibrillation
- Intervention (Device)
- ECG Analysis Software AiTiALVDD
- Intervention (Device)
- ECG Analysis Software AiTiALVSD
- Lead sponsor
- Korea University Anam Hospital
Record details
- Record id
cardio:ct-nct07938281- Content hash
bc0674e00b45e1bd0c9959f9ce9caa5d50d8f70a6edb6d76d45688b46513bcc9